Genmab's blockbuster Darzalex surpasses $2B in sales

Genmab A/S (CSE:GEN; Pink:GMXAY) said sales of its multiple myeloma drug Darzalex daratumumab reached $2 billion in 2018,

Read the full 186 word article

User Sign In